| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 39,594 | 0.00 | 93,301.37 |
| 17 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 29.9582 | 1,853 | 55.51 k | 53,707.37 |
| 6 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 33.812 | 2,816 | 95.21 k | 55,560.37 |
| 16 Jan 24 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 25,445 | 0.00 | 58,376.37 |
| 16 Jan 24 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 66.3 | 37,000 | 2.45 mm | 37,000 |
| 4 Jan 24 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 60.0534 | 2,751 | 165.21 k | 32,931.37 |
